A. Saxena, “Pharmacological Modulation of the Nrf2–Keap1 Pathway in Diabetes: Mechanisms, Therapeutic Advances, and Future Directions”, J. Res. Appl. Sci. Biotechnol., vol. 4, no. 5, pp. 38–63, Oct. 2025.